Insider · CIK 0001812638
Kishor G. Bhatia
officer
Files at LTRN (Lantern Pharma Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 18, 2025 | LTRN Lantern Pharma Inc. | AGrant or award Stock Option (Right to Buy)derivative | +10,000 | $0.00 | $0 | 10,000 | Dec 22, 2025 |
| Jun 15, 2020 | LTRN Lantern Pharma Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -52,200 | $0.00 | $0 | 0 | Sep 23, 2025 |
| Jun 15, 2020 | LTRN Lantern Pharma Inc. | AGrant or award Stock Option (Right to Buy)derivative | +52,200 | $0.00 | $0 | 52,200 | Sep 23, 2025 |
| Oct 29, 2021 | LTRN Lantern Pharma Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -17,400 | $0.00 | $0 | 0 | Sep 23, 2025 |
| Oct 29, 2021 | LTRN Lantern Pharma Inc. | AGrant or award Stock Option (Right to Buy)derivative | +17,400 | $0.00 | $0 | 17,400 | Sep 23, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.